9.6 Fatty Acid Beta-Oxidation, Ketogenesis & Glycogen Dynamics

9.6 Fatty Acid Beta-Oxidation, Ketogenesis & Glycogen Dynamics

During times of nutritional surplus, vertebrates store excess chemical energy as glycogen in liver and muscle, and as triacylglycerols in adipose tissue. During fasting, endurance exercise, or metabolic disease, coordinated neuroendocrine cascades trigger the mobilization and degradation of these macromolecular fuel reserves.

---

Glycogen Dynamics: Structure, Glycogenesis & Glycogenolysis

Glycogen is a branched homopolysaccharide of D-glucose. Glucose residues within linear chains are joined by $\alpha$-1,4-glycosidic bonds, while branch points occur every 8 to 12 residues via $\alpha$-1,6-glycosidic bonds. Branching dramatically increases polymer solubility and multiplies the number of non-reducing ends available for rapid synthesis and enzymatic degradation.

Glycogenesis (Glycogen Synthesis)

Glycogen synthesis initiates on the dimeric self-glucosylating protein primer glycogenin:

1. Activation: Glucose-6-phosphate is isomerized to glucose-1-phosphate (G1P) by phosphoglucomutase. UDP-Glucose Pyrophosphorylase activates G1P using UTP to yield UDP-glucose and inorganic pyrophosphate ($\text{PP}_i$). Subsequent hydrolysis of $\text{PP}_i$ by inorganic pyrophosphatase drives the reaction irreversibly forward.
2. Chain Elongation: Glycogen Synthase (the rate-limiting enzyme of glycogenesis) transfers the glucosyl unit from UDP-glucose to the C4-hydroxyl group of a non-reducing end, establishing an $\alpha$-1,4-glycosidic linkage.
3. Branching: When a linear chain reaches $\approx 11$ residues, Branching Enzyme (amylo-$\alpha$-(1,4 $\to$ 1,6)-transglucosidase) cleaves a terminal 6- to 7-residue block and reattaches it via an $\alpha$-1,6-glycosidic bond at least 4 residues away from existing branches.

Glycogenolysis (Glycogen Breakdown)

1. Phosphorolysis: Glycogen Phosphorylase (the rate-limiting enzyme of glycogenolysis) catalyzes the phosphorolytic cleavage of $\alpha$-1,4 bonds from non-reducing ends using inorganic phosphate ($\text{P}_i$), releasing glucose-1-phosphate (G1P). This phosphorolytic mechanism conserves metabolic energy: the released hexose is already phosphorylated, bypassing the ATP-consuming hexokinase step.
2. Debranching: Glycogen phosphorylase cannot cleave $\alpha$-1,4 bonds within 4 residues of an $\alpha$-1,6 branch point (producing a limit dextrin). The bifunctional Debranching Enzyme resolves this barrier:
   • 4-$\alpha$-Glucanotransferase Activity: Shifts a block of 3 glucosyl units from the limit branch to the non-reducing end of a neighboring linear chain.
   • Amylo-$\alpha$-1,6-Glucosidase Activity: Hydrolytically cleaves the single remaining glucose residue at the branch point, releasing free, unphosphorylated glucose.
   • Stoichiometric Ratio: Glycogenolysis produces approximately 90% glucose-1-phosphate (from phosphorylase) and 10% free glucose (from debranching enzyme).

Liver vs. Muscle Specialization

• Liver Glycogen: Functions as a systemic glucose reservoir to buffer blood glucose levels (70–100 mg/dL). Hepatocytes express Glucose-6-Phosphatase in the endoplasmic reticulum membrane, enabling conversion of G6P to free glucose for export into the blood via GLUT2.
• Skeletal Muscle Glycogen: Dedicated strictly to cell-autonomous generation of ATP during mechanical contraction. Muscle fibers completely lack Glucose-6-Phosphatase; all G1P liberated is converted to G6P and funneled directly into glycolysis. Furthermore, muscle lacks glucagon receptors, responding instead to epinephrine, allosteric AMP, and sarcoplasmic $\text{Ca}^{2+}$.

Reciprocal Hormonal Regulation

• Glucagon (Liver) & Epinephrine (Liver & Muscle): Trigger $G_s$-coupled receptors $\to$ cAMP $\to$ PKA activation. PKA phosphorylates Phosphorylase Kinase, which in turn phosphorylates Glycogen Phosphorylase, transforming it into its active $a$-state. Simultaneously, PKA and GSK-3 phosphorylate Glycogen Synthase, converting it into its inactive $b$-state. Glycogenolysis is maximally stimulated; glycogenesis is shut down.
• Insulin (Fed State): Triggers receptor tyrosine kinase activation $\to$ activates Protein Phosphatase 1 (PP1). PP1 dephosphorylates both enzymes, inactivating Glycogen Phosphorylase and activating Glycogen Synthase, driving glycogen replenishment.

Lipid Mobilization and the Carnitine Transport Shuttle

Triacylglycerols (TAGs) stored in white adipose tissue represent the body's primary energy depot, yielding $9\text{ kcal/g}$ compared to $4\text{ kcal/g}$ for carbohydrates and proteins.

Adipocyte Lipolysis

During fasting or stress, glucagon and epinephrine stimulate Hormone-Sensitive Lipase (HSL) via PKA phosphorylation. HSL and adipose triglyceride lipase (ATGL) hydrolyze TAGs into three free fatty acids (FFAs) and one glycerol molecule. Hydrophobic FFAs are released into the blood, where they bind non-covalently to serum albumin for transport to peripheral tissues.

Fatty Acid Activation (Cytosol)

Upon cellular uptake, fatty acids are activated in the outer mitochondrial membrane by Acyl-CoA Synthetase (Fatty Acid Thiokinase):

$$\text{Fatty Acid} + \text{CoA-SH} + \text{ATP} \xrightleftharpoons{} \text{Fatty Acyl-CoA} + \text{AMP} + \text{PP}_i$$

Inorganic pyrophosphatase immediately hydrolyzes $\text{PP}_i$ to $2\text{ P}_i$ ($\Delta G^{\circ\prime} = -33.5\text{ kJ/mol}$), driving the activation forward. This reaction consumes two high-energy phosphate equivalents (ATP $\to$ AMP $+ 2\text{ P}_i$).

The Carnitine Shuttle

While short- and medium-chain fatty acids ($<12$ carbons) diffuse directly into the mitochondrial matrix, long-chain acyl-CoAs cannot penetrate the inner mitochondrial membrane and require the carnitine shuttle:

1. Carnitine Palmitoyltransferase-1 (CPT-1 / CAT-1): Located on the outer mitochondrial membrane. Transesterifies the fatty acyl group from CoA to the hydroxyl group of carnitine, forming acyl-carnitine and releasing free cytosolic CoA-SH. CPT-1 is the rate-limiting enzyme of fatty acid oxidation.
   • Allosteric Regulation: CPT-1 is potently inhibited by malonyl-CoA, the first committed intermediate of fatty acid synthesis produced by Acetyl-CoA Carboxylase. This prevents futile cycling: when the liver is actively synthesizing lipids in the fed state, $\beta$-oxidation is blocked.
2. Carnitine-Acylcarnitine Translocase (CACT): An antiporter in the inner membrane that shuttles acyl-carnitine into the matrix while exporting free carnitine back to the intermembrane space.
3. Carnitine Palmitoyltransferase-2 (CPT-2 / CAT-2): Located on the inner surface of the inner membrane. Reverses the transesterification, transferring the fatty acyl group onto mitochondrial matrix CoA-SH to regenerate Fatty Acyl-CoA and free carnitine.

---

Mitochondrial Beta-Oxidation: The Four-Step Spiral

In the mitochondrial matrix, fatty acyl-CoA undergoes a recursive four-step cycle that cleaves two carbons from the carboxyl end per turn, producing 1 Acetyl-CoA, 1 $\text{FADH}_2$, and 1 NADH.

The Four Recurring Reactions

1. Oxidation (FAD-Dependent): Acyl-CoA Dehydrogenase introduces a trans double bond between C2 ($\alpha$) and C3 ($\beta$), yielding trans-$\Delta^2$-enoyl-CoA and reducing FAD to $\text{FADH}_2$. (Clinically, medium-chain acyl-CoA dehydrogenase deficiency, MCADD, impairs oxidation of 6- to 12-carbon fatty acids, causing severe fasting hypoketotic hypoglycemia).
2. Hydration: Enoyl-CoA Hydratase stereospecifically adds a water molecule across the trans double bond, generating L-$\beta$-hydroxyacyl-CoA.
3. Oxidation (NAD+-Dependent): $\beta$-Hydroxyacyl-CoA Dehydrogenase oxidizes the $\beta$-hydroxyl group to a keto group, producing $\beta$-ketoacyl-CoA and reducing $\text{NAD}^+$ to NADH + $\text{H}^+$.
4. Thiolytic Cleavage (Thiolysis): $\beta$-Ketothiolase attacks the $\beta$-carbonyl with a fresh molecule of Coenzyme A (CoA-SH), releasing a two-carbon Acetyl-CoA and a fatty acyl-CoA shortened by two carbons ($n - 2$).

Quantitative ATP Yield for Palmitate (16:0)

Palmitate (16 carbons, saturated) requires 7 cycles of $\beta$-oxidation:

• Products of 7 Cycles: $7\text{ FADH}_2 + 7\text{ NADH} + 8\text{ Acetyl-CoA}$
• TCA Oxidation of 8 Acetyl-CoA: $8 \times (3\text{ NADH} + 1\text{ FADH}_2 + 1\text{ GTP}) = 24\text{ NADH} + 8\text{ FADH}_2 + 8\text{ GTP}$
• Total Coenzymes Harvested:
  • $\text{NADH}$: $7 + 24 = 31\text{ NADH} \times 2.5\text{ ATP} = 77.5\text{ ATP}$
  • $\text{FADH}_2$: $7 + 8 = 15\text{ FADH}_2 \times 1.5\text{ ATP} = 22.5\text{ ATP}$
  • $\text{GTP} / \text{ATP}$: $8\text{ ATP}$
  • Gross ATP Yield: $77.5 + 22.5 + 8 = 108\text{ ATP}$
  • Net ATP Yield: $108\text{ ATP} - 2\text{ ATP equivalents (Activation)} = \mathbf{106\text{ Net ATP}}$

Special Cases: Odd-Chain and Unsaturated Fatty Acids

• Odd-Chain Fatty Acids: Undergo standard $\beta$-oxidation until the final thiolysis yields 1 Acetyl-CoA (2C) and 1 Propionyl-CoA (3C). Propionyl-CoA is converted to the TCA cycle intermediate succinyl-CoA via three steps:
  1. Carboxylation by Propionyl-CoA Carboxylase (requires Biotin / Vitamin $\text{B}_7$ and ATP) to D-methylmalonyl-CoA.
  2. Epimerization to L-methylmalonyl-CoA.
  3. Intramolecular rearrangement by Methylmalonyl-CoA Mutase (requires Vitamin $\text{B}_{12}$ / Cobalamin) to succinyl-CoA.
  • MCAT Crucial Distinction: Because succinyl-CoA can be converted via malate into oxaloacetate for gluconeogenesis, odd-chain fatty acids are glucogenic. Even-chain fatty acids can never yield net glucose in humans.
• Unsaturated Fatty Acids: Cis double bonds present stereochemical barriers to enoyl-CoA hydratase. Isomerase (converting cis-$\Delta^3$ bonds to trans-$\Delta^2$) and 2,4-dienoyl-CoA reductase (for polyunsaturated chains) resolve these impediments, yielding slightly less ATP because the first dehydrogenation step is bypassed.

---

Ketogenesis, Extrahepatic Ketolysis & Diabetic Ketoacidosis (DKA)

The Physiological Trigger for Ketogenesis

During prolonged fasting (>24–48 hours), extreme starvation, or untreated Type 1 Diabetes Mellitus, adipose lipolysis floods hepatocytes with massive quantities of fatty acids. Hepatic $\beta$-oxidation produces vast surpluses of acetyl-CoA.

Simultaneously, active hepatic gluconeogenesis depletes the matrix pool of oxaloacetate (OAA) (diverting it to PEP). Furthermore, the high [NADH]/[$\text{NAD}^+$] ratio from $\beta$-oxidation pushes the malate dehydrogenase equilibrium toward malate. Deprived of sufficient OAA, the excess acetyl-CoA cannot condense into citrate and is shunted into ketogenesis in the mitochondria of hepatocytes.

Hepatic Ketogenesis Pathway

1. Condensation: Two molecules of acetyl-CoA condense via Thiolase to form acetoacetyl-CoA.
2. HMG-CoA Synthesis: Mitochondrial HMG-CoA Synthase (the rate-limiting enzyme of ketogenesis) condenses acetoacetyl-CoA with a third acetyl-CoA to form $\beta$-hydroxy-$\beta$-methylglutaryl-CoA (HMG-CoA). (Note: Cytosolic HMG-CoA synthase participates in cholesterol biosynthesis).
3. Cleavage: HMG-CoA Lyase cleaves HMG-CoA to yield Acetoacetate and free acetyl-CoA.
4. Reduction / Decarboxylation:
   • $\beta$-Hydroxybutyrate Dehydrogenase reversibly reduces acetoacetate to $\beta$-hydroxybutyrate using NADH.
   • A small portion of acetoacetate undergoes spontaneous non-enzymatic decarboxylation into volatile acetone, which is expired through the lungs (producing the characteristic fruity breath odor).

Extrahepatic Ketolysis (Ketone Utilization)

Acetoacetate and $\beta$-hydroxybutyrate are water-soluble organic acids that diffuse into the blood without needing carrier proteins. Peripheral tissues—including cardiac muscle, skeletal muscle, renal cortex, and, after adaptation during prolonged starvation, the brain (which derives up to 60–70% of its energy from ketones, sparing muscle protein degradation)—take up ketone bodies and oxidize them back to acetyl-CoA:

1. $\beta$-Hydroxybutyrate is oxidized to acetoacetate by $\beta$-hydroxybutyrate dehydrogenase, generating NADH.
2. Acetoacetate is activated to acetoacetyl-CoA by $\beta$-Ketoacyl-CoA Transferase (Thiophorase), transferring a CoA moiety from succinyl-CoA (succinyl-CoA $\to$ succinate).
3. Thiolase cleaves acetoacetyl-CoA with CoA-SH to yield two molecules of Acetyl-CoA, which enter the Citric Acid Cycle.

The Cardinal MCAT Fact: The liver CANNOT utilize ketone bodies for fuel because hepatocytes completely lack $\beta$-Ketoacyl-CoA Transferase (Thiophorase). The liver functions strictly as a ketone producer, never a consumer.

Diabetic Ketoacidosis (DKA) Pathophysiology

In untreated Type 1 Diabetes Mellitus, the complete absence of insulin produces an extreme perceived starvation state:

• Unchecked HSL activity drives runaway lipolysis, flooding the liver with fatty acids.
• Massive hepatic ketogenesis produces acetoacetic acid and $\beta$-hydroxybutyric acid at rates far exceeding peripheral clearance.
• These organic acids dissociate completely at physiological pH ($pK_a \approx 3.5–4.5$), overwhelming the bicarbonate buffering system and precipitating a severe high anion gap metabolic acidosis (blood $\text{pH} < 7.3$, serum $\text{HCO}_3^- < 15\text{ mEq/L}$).
• Respiratory compensation manifests as rapid, deep Kussmaul breathing to blow off acidic $\text{CO}_2$.

Comparison of Fatty Acid $\beta$-Oxidation and Fatty Acid Synthesis